A Portland medical technology startup, MedRhythms Inc., is continuing to develop its product pipeline with the formation of two scientific advisory boards and the start of a new clinical trial.
MedRhythms, whose patented digital platform uses music and biosensors to treat neurologically linked walking impairment, has created boards to guide the company’s product research in multiple sclerosis and Parkinson’s disease, according to a news release Tuesday. Read more
